AstraZeneca pledges $50bn investment in the US amid 200% tariff fears

Written by

in

British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

Continue Reading

More posts

Ukraine’s controversial restructuring of its anti-corruption agencies concerns the West.

July 22, 2025
Ukrainian intelligence reveals data on new Russian recon drone built entirely from Chinese parts

July 22, 2025
Deteriorating relations with Trump will not compel Putin to end the war; Russia plans extensive rearmament.

July 22, 2025
Energy system integration: Ukraine’s parliament approves draft law on unification of Ukrainian and EU electricity markets.

July 22, 2025